Physician

Adam Stern, M.D.

According to 2025 Medicare claims, Adam Stern, M.D. (NPI: 1376769893) practices nephrology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is NORTH CAROLINA NEPHROLOGY PA (NPI: 1750835336; TIN: 81-2808787) and primary practice location at 27616-2955.

Stern's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 539 traditional Medicare patients, billed 1,754 HCPCS/CPT codes, and received $153,617 in Medicare payments. The top billing code was 36902 (Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist). Part D data shows 1,227 prescription claims across 218 beneficiaries totaling $242,196 in drug costs, led by Jardiance (Empagliflozin). 2017 DME data shows 26 claims. Open Payments data shows 51 records totaling $1,123. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $258,486 to $153,617. In contrast, Part D prescription costs have risen steadily, from $103,550 to $242,196. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	691	3,272	$258,486
2016	766	8,110	$562,831
2017	806	11,742	$586,207
2018	788	13,208	$652,290
2019	821	18,216	$765,237
2020	826	22,687	$873,115
2021	666	10,360	$419,014
2022	595	3,866	$280,633
2023	475	1,317	$146,073
2024	539	1,754	$153,617

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	191	1,372	$103,550
2016	181	1,081	$225,461
2017	145	745	$73,931
2018	147	731	$76,977
2019	160	828	$113,648
2020	134	870	$153,398
2021	144	790	$152,059
2022	153	835	$181,384
2023	204	1,067	$284,333
2024	218	1,227	$242,196

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	26	$801
2016	N/R	51	$2,315
2017	N/R	26	$1,090
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
36902	Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist	58	65	$171
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	62	112	$88
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	160	287	$58
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	156	279	$56
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	142	241	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	90	3,720	$70,628
Farxiga	Dapagliflozin Propanediol	93	3,494	$63,900
Ozempic	Semaglutide	18	686	$20,054
Lokelma	Sodium Zirconium Cyclosilicate	13	446	$9,429
Januvia	Sitagliptin Phosphate	11	330	$6,136

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	51	$1,123	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam Stern, M.D.?

Tedicare shows public-source Medicare data for Adam Stern, M.D. (NPI 1376769893), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Stern, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Stern, M.D.?

Adam Stern, M.D. is linked to NORTH CAROLINA NEPHROLOGY PA (billing NPI 1750835336) in the available physician profile data.

Does Adam Stern, M.D. have Open Payments data?

Adam Stern, M.D. has 51 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.